Study to understand clinical characteristics, treatment pathway in chronic lymphocytic leukemia - CREEK

Study identifier:D8220R00031

ClinicalTrials.gov identifier:NCT04964908

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

CREEK is a Multicenter Retrospective Study to understand the clinical characteristics, treatment pathway and resource utilization for patients with chronic lymphocytic leukemia in international region.

Medical condition

Chronic Lymphocytic Leukemia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual Enrollment

1088

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 03 Dec 2021
Primary Completion Date: 31 Aug 2023
Study Completion Date: 31 Aug 2023

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria